{
  "id": 812851,
  "title": "BioSyent Schedules Q2 and H1 2026 Earnings Release for August 20, 2026",
  "url": "https://urgent.news/2026/08/13/biosyent-schedules-q2-and-h1-2026-earnings-release-for-august-20-2026",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-13T21:33:00.000Z",
  "source": {
    "name": "Financial Post",
    "slug": "financial-post",
    "url": "https://financialpost.com/globe-newswire/biosyent-schedules-q2-and-h1-2026-earnings-release-for-august-20-2026"
  },
  "original_language": "en",
  "account": null,
  "summary": "MISSISSAUGA, Ontario, Aug. 13, 2026 (GLOBE NEWSWIRE) — BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its consolidated financial results for the three and six months ended June 30, 2026 on Thursday, August 13, 2026 after market hours. A presentation on the Company’s second quarter and first half 2026 results by René […]",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}